Effectiveness and safety of finerenone in diabetic kidney disease patients: a real-world observational study from China.
在中國進行的真實世界觀察研究:finerenone 在糖尿病腎病患者中的有效性和安全性。
Ren Fail 2024-09-09
Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysis.
Finerenone在2型糖尿病和腎臟結果中的隨機效應模型荟萃分析。
Front Endocrinol (Lausanne) 2023-03-14
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
Finerenone在慢性腎臟病和2型糖尿病亞洲患者中的心腎結果:FIDELIO-DKD事後分析。
Am J Nephrol 2023-12-13
Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease.
Finerenone:朝向對糖尿病腎病患者的整全治療方法。
Nefrologia (Engl Ed) 2024-01-30
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD.
慢性腎臟病和2型糖尿病患者中 finerenone 的藥物動力學和藥效學:基於 FIGARO-DKD 和 FIDELIO-DKD 的見解。
Diabetes Obes Metab 2024-02-08
Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China.
Finerenone在患有慢性腎臟病和2型糖尿病的患者中的應用:來自中國的FIDELIO-DKD次群。
Kidney Dis (Basel) 2023-12-13
The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials.
Finerenone作為糖尿病腎病的新型治療選擇的重要性:以finerenone第3期試驗的心腎結果為重點的範圍性回顧。
Front Med (Lausanne) 2024-07-01
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison.
慢性腎病與2型糖尿病患者中 Finerenone 與 Canagliflozin 的比較療效:匹配調整間接比較。
J Mark Access Health Policy 2024-08-28
Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan-A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform.
日本慢性腎病與2型糖尿病患者中Finerenone的早期臨床經驗—來自FOUNTAIN(FinerenOne多數據庫網絡證據生成)平台的多隊列研究。
J Clin Med 2024-09-14